Breast Cancer Research and Treatment View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1981

PUBLISHER

Springer US

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/10549

Recent publications latest 20 shown

  • 2019-04-12 Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms.
  • 2019-04-12 The association between mammographic density and breast cancer risk in Western Australian Aboriginal women.
  • 2019-04-12 Randomised clinical endpoint studies for trastuzumab biosimilars: a systematic review.
  • 2019-04-11 Improving surgical efficiency of immediate implant-based breast reconstruction following mastectomy.
  • 2019-04-11 Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1).
  • 2019-04-11 Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer.
  • 2019-04-10 Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer.
  • 2019-04-10 Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference?
  • 2019-04-06 Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval.
  • 2019-04-06 Effects of physical and mind-body exercise on sleep problems during and after breast cancer treatment: a systematic review and meta-analysis.
  • 2019-04-06 Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women.
  • 2019-04-05 Breast cancer research and treatment reconstruction of unilateral breast structure using three-dimensional ultrasound imaging to assess breast neoplasm.
  • 2019-04-04 Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues.
  • 2019-04-04 GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event.
  • 2019-04-02 Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer
  • 2019-04-02 Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
  • 2019-04 Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
  • 2019-04 A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types
  • 2019-04-01 4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion
  • 2019-04 The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies
  • Subjects

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33160", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Oncology", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.208", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "2.066", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2017", 
            "ratingValue": "3.605", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "3.626", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "4.085", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "3.940", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "4.198", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "4.859", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "4.696", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "4.469", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "4.431", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2008", 
            "ratingValue": "5.684", 
            "type": "Rating"
          }
        ], 
        "description": "

    Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a \"market place\" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.

    Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these journals provides a focus on the unique problems of breast cancer. There has been no convenient arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. Breast Cancer Research and Treatment aims to fill this need.

    Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics.There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer.

    ", "editor": [ { "familyName": "Lippman", "givenName": "Marc", "type": "Person" } ], "id": "sg:journal.1092777", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0167-6806", "1573-7217" ], "license": "Hybrid (Open Choice)", "name": "Breast Cancer Research and Treatment", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "92777" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "10549" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn 82002391" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "0167-6806/BREAST CANCER RESEARCH AND TREATMENT" ] }, { "name": "scopus_id", "type": "PropertyValue", "value": [ "28766" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "8111104" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "342632" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "15824" ] } ], "publisher": { "name": "Springer US", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1092777" ], "sdDataset": "journals", "sdDatePublished": "2021-01-19T05:00", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///pack/app/journals_20190313_sn_only.jsonl", "startYear": "1981", "type": "Periodical", "url": "http://link.springer.com/journal/10549" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1092777'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1092777'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1092777'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1092777'


     

    This table displays all metadata directly associated to this object as RDF triples.

    146 TRIPLES      21 PREDICATES      41 URIs      36 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1092777 schema:about sg:ontologies/product-market-codes/H33160
    2 schema:contentRating N0e4b8f17e55b45f0a3654dddbe503df5
    3 N24cff60d8f6c4009adbc93d3a2f652ac
    4 N25a457b754dd48459b65a94d77ae60d7
    5 N36dfc4f068f8481ab6de799efa4d1284
    6 N47d2910acb284256938debfe71dc22e6
    7 N4d96fba00c8645deb19a82340b329ee9
    8 N8e7f79a56a05481fb0b2bb6e7b1f85c2
    9 N9219ac310dc844b9bff47b483a37cae9
    10 Na219790d5fbb407ab34e3ba2b2885170
    11 Nb75d6c6fc41849c095e892aaf00185ac
    12 Nd39ac6ea893249ba842481fd19785c8f
    13 Ndd28e041ab3544a0a1f0be4b1587ce8b
    14 schema:description <p><i>Breast Cancer Research and Treatment</i> provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.<br/><br/>Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these journals provides a focus on the unique problems of breast cancer. There has been no convenient arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. <i>Breast Cancer Research and</i> <i>Treatment</i> aims to fill this need.<br/><br/>Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics.There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer. </p>
    15 schema:editor Ne6a7651968bd48989e63eb9a22ab3221
    16 schema:inLanguage en
    17 schema:isAccessibleForFree false
    18 schema:issn 0167-6806
    19 1573-7217
    20 schema:license Hybrid (Open Choice)
    21 schema:name Breast Cancer Research and Treatment
    22 schema:productId N2d202aa570b64cc5bc285b65d7f67381
    23 N4345fabe4ae846d3bee5af4daccce167
    24 N566baca45dba4f579dd2177dbaab2392
    25 N62e2e69ba5034581bbeee65dc4c55682
    26 N8be700e449a04336b715d67dab08e966
    27 Nb1237193a7e64926bb31ed1ebe28c9be
    28 Nd89a3d0c63004770b472900d9840680b
    29 Ned31fdbde98f429f8d3a6bf695a222a3
    30 schema:publisher N9fcdcc0fd93b4d998ce938bd2f313f44
    31 schema:publisherImprint Springer
    32 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1092777
    33 schema:sdDatePublished 2021-01-19T05:00
    34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    35 schema:sdPublisher N4d33ca802de448efb606e77b94aba7f5
    36 schema:startYear 1981
    37 schema:url http://link.springer.com/journal/10549
    38 sgo:license sg:explorer/license/
    39 sgo:sdDataset journals
    40 rdf:type schema:Periodical
    41 N042ebf7371764d35b54ce6c21a280213 rdf:first impact_factor_wos
    42 rdf:rest rdf:nil
    43 N06febcc1474b436d96a394f627668975 rdf:first impact_factor_wos
    44 rdf:rest rdf:nil
    45 N0e4b8f17e55b45f0a3654dddbe503df5 schema:author N64cd124c1a704fe78876ecd0101bae66
    46 schema:dateCreated 2014
    47 schema:ratingValue 3.940
    48 rdf:type schema:Rating
    49 N24cff60d8f6c4009adbc93d3a2f652ac schema:author Nc7aa5a0b871f49f3bf99cfd62d7c38df
    50 schema:dateCreated 2010
    51 schema:ratingValue 4.859
    52 rdf:type schema:Rating
    53 N25a457b754dd48459b65a94d77ae60d7 schema:author N8391628fc99a4036a970f75ded7018c2
    54 schema:dateCreated 2013
    55 schema:ratingValue 4.198
    56 rdf:type schema:Rating
    57 N2d202aa570b64cc5bc285b65d7f67381 schema:name wos_id
    58 schema:value 0167-6806/BREAST CANCER RESEARCH AND TREATMENT
    59 rdf:type schema:PropertyValue
    60 N36dfc4f068f8481ab6de799efa4d1284 schema:author Nf92867adbd794c3a883952be34bb5796
    61 schema:ratingValue 1.208
    62 rdf:type schema:Rating
    63 N4345fabe4ae846d3bee5af4daccce167 schema:name lccn_id
    64 schema:value sn 82002391
    65 rdf:type schema:PropertyValue
    66 N4484aabe1f364fd6b1ba134b58f0cc55 rdf:first impact_factor_wos
    67 rdf:rest rdf:nil
    68 N47d2910acb284256938debfe71dc22e6 schema:author N4484aabe1f364fd6b1ba134b58f0cc55
    69 schema:dateCreated 2017
    70 schema:ratingValue 3.605
    71 rdf:type schema:Rating
    72 N4d33ca802de448efb606e77b94aba7f5 schema:name Springer Nature - SN SciGraph project
    73 rdf:type schema:Organization
    74 N4d96fba00c8645deb19a82340b329ee9 schema:author N956f518ec42a456ebfbdc2c37a212d29
    75 schema:dateCreated 2012
    76 schema:ratingValue 4.469
    77 rdf:type schema:Rating
    78 N566baca45dba4f579dd2177dbaab2392 schema:name era_ids_id
    79 schema:value 15824
    80 rdf:type schema:PropertyValue
    81 N62e2e69ba5034581bbeee65dc4c55682 schema:name nsd_ids_id
    82 schema:value 342632
    83 rdf:type schema:PropertyValue
    84 N64cd124c1a704fe78876ecd0101bae66 rdf:first impact_factor_wos
    85 rdf:rest rdf:nil
    86 N8391628fc99a4036a970f75ded7018c2 rdf:first impact_factor_wos
    87 rdf:rest rdf:nil
    88 N8be700e449a04336b715d67dab08e966 schema:name scopus_id
    89 schema:value 28766
    90 rdf:type schema:PropertyValue
    91 N8e7f79a56a05481fb0b2bb6e7b1f85c2 schema:author Nb1e2867fef5f4af88019e93b9d911ca6
    92 schema:dateCreated 2009
    93 schema:ratingValue 4.696
    94 rdf:type schema:Rating
    95 N9219ac310dc844b9bff47b483a37cae9 schema:author N9e42420c0221483ea7d95ac3397af6d4
    96 schema:ratingValue 2.066
    97 rdf:type schema:Rating
    98 N956f518ec42a456ebfbdc2c37a212d29 rdf:first impact_factor_wos
    99 rdf:rest rdf:nil
    100 N9e42420c0221483ea7d95ac3397af6d4 rdf:first sjr
    101 rdf:rest rdf:nil
    102 N9fcdcc0fd93b4d998ce938bd2f313f44 schema:name Springer US
    103 rdf:type schema:Organization
    104 Na219790d5fbb407ab34e3ba2b2885170 schema:author N06febcc1474b436d96a394f627668975
    105 schema:dateCreated 2011
    106 schema:ratingValue 4.431
    107 rdf:type schema:Rating
    108 Nb1237193a7e64926bb31ed1ebe28c9be schema:name springer_id
    109 schema:value 10549
    110 rdf:type schema:PropertyValue
    111 Nb1e2867fef5f4af88019e93b9d911ca6 rdf:first impact_factor_wos
    112 rdf:rest rdf:nil
    113 Nb381a7c0a7d6460ba7c92feccd4419c4 schema:familyName Lippman
    114 schema:givenName Marc
    115 rdf:type schema:Person
    116 Nb5481c01d3554c288ce2c255100c0519 rdf:first impact_factor_wos
    117 rdf:rest rdf:nil
    118 Nb75d6c6fc41849c095e892aaf00185ac schema:author Nf5de84dfaae647ff99f47c65f4f55cbd
    119 schema:dateCreated 2008
    120 schema:ratingValue 5.684
    121 rdf:type schema:Rating
    122 Nc7aa5a0b871f49f3bf99cfd62d7c38df rdf:first impact_factor_wos
    123 rdf:rest rdf:nil
    124 Nd39ac6ea893249ba842481fd19785c8f schema:author Nb5481c01d3554c288ce2c255100c0519
    125 schema:dateCreated 2016
    126 schema:ratingValue 3.626
    127 rdf:type schema:Rating
    128 Nd89a3d0c63004770b472900d9840680b schema:name dimensions_id
    129 schema:value 92777
    130 rdf:type schema:PropertyValue
    131 Ndd28e041ab3544a0a1f0be4b1587ce8b schema:author N042ebf7371764d35b54ce6c21a280213
    132 schema:dateCreated 2015
    133 schema:ratingValue 4.085
    134 rdf:type schema:Rating
    135 Ne6a7651968bd48989e63eb9a22ab3221 rdf:first Nb381a7c0a7d6460ba7c92feccd4419c4
    136 rdf:rest rdf:nil
    137 Ned31fdbde98f429f8d3a6bf695a222a3 schema:name nlm_unique_id
    138 schema:value 8111104
    139 rdf:type schema:PropertyValue
    140 Nf5de84dfaae647ff99f47c65f4f55cbd rdf:first impact_factor_wos
    141 rdf:rest rdf:nil
    142 Nf92867adbd794c3a883952be34bb5796 rdf:first snip
    143 rdf:rest rdf:nil
    144 sg:ontologies/product-market-codes/H33160 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    145 schema:name Oncology
    146 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...